Advancedbiotechnology

Next-Generation Sequencing

Overview

Next-generation sequencing parallelizes millions of reactions: Illumina's reversible-terminator bridge amplification reads ~150-300 bp clusters by fluorescent cycles; long-read platforms (PacBio, Oxford Nanopore) read kilobases to megabases. NGS dropped genome cost from 3Bto 3B to ~600, enabling cancer profiling, non-invasive prenatal testing, pathogen surveillance, and population genomics.

Learning objectives

  • Explain Illumina sequencing-by-synthesis
  • Compare short-read vs long-read platforms
  • List major NGS applications
  • Explain coverage and depth

Illumina chemistry

DNA is fragmented, adapter-ligated, and bridge-amplified into clonal clusters on a flow cell. Cycles add fluorescent reversible terminators (one base per cycle), imaged, then dye cleaved and 3'-OH unblocked. Millions of clusters read in parallel: 150-300 bp reads, ~99.9% accuracy, terabases per run.

Reversible terminators

Block-then-unblock chemistry lets every cluster add exactly one base per imaged cycle.

Long reads

PacBio SMRT: polymerase watched in real time (HiFi reads: ~99.9% at 10-25 kb). Oxford Nanopore: DNA threaded through protein pores, current changes read bases (megabase reads, portable MinION). Long reads resolve repeats, structural variants, and complete telomere-to-telomere assemblies.

T2T needed long reads

Only long reads could assemble centromeres and segmental duplications: the 2022 complete genome.

Applications

Whole-genome/exome sequencing (rare disease diagnosis: ~40% solve rate), tumor profiling (targeted therapy), liquid biopsy (ctDNA), NIPT (fetal DNA in maternal blood), microbiome 16S/metagenomics, COVID variant surveillance, and UK Biobank-scale population genomics.

Interpretation bottleneck

Sequencing is cheap; interpreting variants (VUS) is the hard, human-limited step.

Depth and coverage

Depth: how many reads cover each base (30x standard for genomes; 500x+ for rare tumor variants). Breadth: fraction of genome covered. More depth finds rarer variants but costs more: experimental design balances the two.

30x genomes, 500x tumors

Depth follows the question: germline vs rare somatic variants.

Key points

  • Illumina: reversible terminators on clonal clusters, massively parallel
  • Long reads (PacBio/Nanopore) resolve repeats and structural variants
  • Applications: rare disease, oncology, NIPT, microbiomes, surveillance
  • Depth = reads per base; design balances depth, breadth, cost

Common misconceptions

✗ Myth: NGS is always more accurate than Sanger.

✓ Truth: Per-base, Sanger still wins (~99.99% vs ~99.9%); NGS wins on scale and consensus accuracy.

✗ Myth: A genome sequence is a diagnosis.

✓ Truth: Most variants are benign or VUS; interpretation needs phenotype, family, and functional data.

Practice questions

Q1. Illumina sequencing uses
  1. Chain termination
  2. Reversible-terminator sequencing-by-synthesis on clusters
  3. Pore currents
  4. Sanger gels
Answer: B.

Fluorescent blocked nucleotides, one base per cycle, imaged across millions of clusters.

Q2. Long-read sequencing's main advantage is
  1. Lower cost per base
  2. Resolving repeats and structural variants
  3. Faster
  4. No DNA needed
Answer: B.

Kilobase-megabase reads span repetitive regions short reads cannot.

Q3. In NGS, 'depth' means
  1. Genome size
  2. Number of reads covering each base
  3. Read length
  4. Cost
Answer: B.

30x depth = each base read ~30 times on average.

Click a question to reveal the answer and explanation.

Frequently asked questions

What is ctDNA?

Circulating tumor DNA in blood: enables liquid biopsies for cancer detection and monitoring.

How did NGS help COVID?

Global sequencing tracked variants (Alpha, Delta, Omicron) in near-real time: genomic epidemiology.

What is the $1000 genome status?

Achieved ~2014, now ~$200-600: the NHGRI's goal drove the entire NGS revolution.